Načítá se...
Establishing a biologics service for patients with inflammatory bowel disease
The use of anti-TNF therapy in the management of Crohn's disease and, to a lesser extent ulcerative colitis, is increasing. This article aims to discuss the practicalities of establishing a biologics service for patients with inflammatory bowel disease. Current guidelines on the use of these dr...
Uloženo v:
| Vydáno v: | Frontline Gastroenterol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5517220/ https://ncbi.nlm.nih.gov/pubmed/28839597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/fg.2010.003558 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|